v3.25.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Consolidated net income $ 32,751 $ 25,099
Loss from discontinued operations, net of tax 0 43
Adjustments to reconcile net income to net cash provided by operating activities:    
Loss on extinguishment of debt 1,235 0
Loss on sale of property, plant, and equipment 45 7
Loss on investments 194 2,722
Depreciation and other amortization expense 2,893 1,743
Amortization of other intangible assets 612 610
Amortization of deferred financing costs 872 1,393
Deferred income tax expense 2,716 363
Stock compensation expense 3,292 3,951
Noncash lease income (728) (85)
Loss on MSA investments 0 6
Changes in operating assets and liabilities:    
Accounts receivable (20,504) (2,563)
Inventories (8,604) (5,145)
Other current assets (5,486) 3,088
Other assets (4,087) (279)
Accounts payable 14,187 3,154
Accrued liabilities and other 9,842 (3,033)
Operating cash flows from continuing operations 29,230 31,074
Operating cash flows from discontinued operations 0 5,003
Net cash provided by operating activities 29,230 36,077
Cash flows from investing activities:    
Capital expenditures (6,176) (2,858)
Proceeds on the sale of property, plant and equipment 0 2
Payment for equity investments (2,783) 0
Purchases of investments (4,079) (7,934)
Proceeds from sale of investments 4,460 3,314
Purchases of non-marketable equity investments 0 (500)
MSA escrow deposits, net (48) 4
Investing cash flows from continuing operations (8,626) (7,972)
Investing cash flows from discontinued operations 0 0
Net cash used in investing activities (8,626) (7,972)
Cash flows from financing activities:    
Redemption of 2026 Notes (250,000) 0
Proceeds from 2032 Notes 300,000 0
Payment of dividends (2,731) (2,407)
Payment of financing costs (7,251) (133)
Exercise of options 4,921 900
Redemption of options (33) (4)
Redemption of restricted stock units (1,970) (840)
Redemption of performance based restricted stock units (2,624) (1,212)
Common stock repurchased 0 (3,051)
Financing cash flows from continuing operations 40,312 (6,747)
Financing cash flows from discontinued operations 0 0
Net cash provided by (used in) financing activities 40,312 (6,747)
Net increase in cash 60,916 21,358
Effect of foreign currency translation on cash 20 (76)
Unrestricted 48,941 117,886
Restricted 1,961 4,929
Total cash at beginning of period 50,902 122,815
Unrestricted 109,925 142,159
Restricted 1,913 1,938
Total cash at end of period 111,838 144,097
Supplemental schedule of noncash investing activities:    
Accrued capital expenditures 168 0
Investment acquired in exchange for net assets held for sale 10,496 0
Supplemental schedule of noncash financing activities:    
Dividends declared not paid $ 1,382 $ 1,279